Stomach pain, a common ailment, can range from simple indigestion to serious conditions like appendicitis. Identifying the ...

Nikki Farrington, 46, started experiencing heavier periods and a "sharp pain" in her side and stomach in March 2023 - and was ...

Anyone who has ever been blighted by acne will know how downright miserable the skin condition can make you. It's highly ...

Jessie J has emotionally revealed that she feels like breast cancer 'robbed her of time with her son' as she gave an update ...

Regular exercise, including morning Tai Chi is already underway, as well as a much more fresh food diet, with less processed ...

Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

The liver, a crucial organ, faces stress from toxins and poor lifestyle choices, leading to potential dysfunction. Early ...

Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

An announcement from Medivir AB ( ($SE:MVIR) ) is now available. Medivir AB’s interim report highlights the potential of its drug candidate, ...

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. About 14.9 million U.S.